PRF Technologies Ltd. (PRFX) stock
PRFXNasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.79+0.04 (+5.82%)
Close on Nov 12, 2026Market cap $653.53KP/E –Yield –
PRF Technologies EPS
Diluted earnings per share is net income divided by the share count including options and convertible securities.
For fiscal 2025 it was -$7.47. The highest annual figure on record is -$7.47 in fiscal 2025.
Annual eps
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$7.47 | – |
| FY2024 | Dec 31, 2024 | -$105.52 | – |
| FY2023 | Dec 31, 2023 | -$122.94 | – |
| FY2022 | Dec 31, 2022 | -$63.46 | – |
| FY2021 | Dec 31, 2021 | -$56.19 | – |
| FY2020 | Dec 31, 2020 | -$94.45 | – |
| FY2019 | Dec 31, 2019 | -$315.10 | – |
| FY2018 | Dec 31, 2018 | -$244.82 | – |
- Revenue
- Gross Profit
- Operating Income
- Net Income
- EBITDA
- Free Cash Flow
- Operating Cash Flow
- R&D Expenses
- Gross Margin
- Operating Margin
- Profit Margin
- Total Debt
- Cash
- Total Assets
- Shares Outstanding
- Market Cap
- Enterprise Value
- PE Ratio
- Price to Sales Ratio
- Price to Book Ratio
- EV/EBITDA
- Price to Free Cash Flow
- All statistics
See a number that looks wrong?